Back to Search
ASSY YACOUB, D.O.
D.O.
Internal Medicine Physician
NPI: 1760478234Individual
Specialties, Licenses & Credentials
Research & Publications (20)
The rapid molecular subtyping and pathotyping of avian influenza viruses.
PMID 19026689·J Virol Methods·2009
7-preclinical
Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms.
PMID 19483104·Mol Pharmacol·2009
8-other
Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 whereas oncogenic Ras is a dominant predictor for resistance.
PMID 19117997·Cancer Res·2009
7-preclinical
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism.
PMID 19417161·Mol Cancer Ther·2009
8-other
Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo.
PMID 19276168·Mol Cancer Ther·2009
7-preclinical
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
PMID 18376144·Cancer Biol Ther·2008
7-preclinical
Human chorionic gonadotropin (hCG) interacts with lovastatin and ionizing radiation to modulate prostate cancer cell viability in vivo.
PMID 18379195·Cancer Biol Ther·2008
7-preclinical
Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation.
PMID 18544666·Mol Pharmacol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 310 W LOSEY ST
SCOTT AFB, IL 62225 - Phone
- (618) 256-3434
Quick Facts
- NPI
- 1760478234
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile